SOCS3 and hepatocellular carcinoma: In fact, LXR enhances, at a transcriptional level, the cytostatic and pro-apoptotic effects of transforming growth factor beta (TGFβ-1) [121] and inhibits HCC cell proliferation by through activation of suppressor of cytokine signalling 3 (SOCS3) [122].